| Literature DB >> 19849852 |
Hongwei Wang1, Dacheng Peng, Jingtian Xie.
Abstract
Ginseng root is used more often than other parts such as leaf stem although extracts from ginseng leaf-stem also contain similar active ingredients with pharmacological functions. Ginseng's leaf-stems are more readily available at a lower cost than its root. This article reviews the pharmacological effects of ginseng leaf-stem on some diseases and adverse effects due to excessive consumption. Ginseng leaf-stem extract contains numerous active ingredients, such as ginsenosides, polysaccharides, triterpenoids, flavonoids, volatile oils, polyacetylenic alcohols, peptides, amino acids and fatty acids. The extract contains larger amounts of the same active ingredients than the root. These active ingredients produce multifaceted pharmacological effects on the central nervous system, as well as on the cardiovascular, reproductive and metabolic systems. Ginseng leaf-stem extract also has anti-fatigue, anti-hyperglycemic, anti-obesity, anti-cancer, anti-oxidant and anti-aging properties. In normal use, ginseng leaf-stem extract is quite safe; adverse effects occur only when it is over dosed or is of poor quality. Extracts from ginseng root and leaf-stem have similar multifaceted pharmacological activities (for example central nervous and cardiovascular systems). In terms of costs and source availability, however, ginseng leaf-stem has advantages over its root. Further research will facilitate a wider use of ginseng leaf-stem.Entities:
Year: 2009 PMID: 19849852 PMCID: PMC2770043 DOI: 10.1186/1749-8546-4-20
Source DB: PubMed Journal: Chin Med ISSN: 1749-8546 Impact factor: 5.455
Major pharmacological effects of ginseng leaf-stem extracts
| CNS-depression effects | -- | Mice | [ |
| Anti-electroconvulsive shock | 50 mg/kg × 7 days | Rats | [ |
| Improving memory | 11.25 g/kg | Rats | [ |
| Protecting cardiac cell | 20 mg/kg iv; 54,27,13.5 mg/kg | Dogs; rats | [ |
| Preventing coronary vascular dysfunction | 120 mg/kg | Rats | [ |
| Antagonizing (NE, KCl, CaCl2) effects | 0.03-3 mg/min | Rabbits; guinea pigs | [ |
| Anti-CHD effects | -- | Patients | [ |
| Effects on ANP gene expression | 50 mg/kg × 7 d | Rats | [ |
| Increasing body weight | -- | Young mice and rats | [ |
| Effects on lipid metabolism | -- | Hyperlipidemic mice | [ |
| Regulating lipid metabolism | 60 mg/kg | Rabbits | [ |
| Anti-diabetic effects | -- | Diabetic patients | [ |
| Anti-hyperglycemic effects | -- | Mice, rats | [ |
| Lowering blood glucose | 150 mg/kg × 12 d | [ | |
| Increasing blood insulin | -- | Mice; rats | [ |
| Hypoglycemic activities | 200 mg/kg × 12 d | [ | |
| Decreasing body weight | 150 mg/kg × 12 d | [ | |
| Anti-prostate, bladder and renal cancer | -- | Patients | [ |
| Killing cancer cells via at least 5 pathways | -- | Normal and cancer cells | [ |
| Reducing apoptotic cell number | 60-140 mg/kg | Mouse cells | [ |
| Suppressing antioxidant enzyme activity | 40-200 mg/kg | Diabetic rats | [ |
| Antioxidant property in cardiac cells | 0.25-1 mg/ml | Rat cultured cardiac cells | [ |
| Restoring free radical-damaged cells | 30 μg/ml (Rb1,2,3) | Cultured myocardiomyocytes | [ |
| Anti-fatigue | 100/200 mg/kg | Rats | [ |
| Anti-ulcer | 100 mg/kg | Mice | [ |
| Anti-diuretic | -- | Rats | [ |
| Anti-aging | -- | Patients | [ |
| Anti-foot-and-mouth disease | 10 μg* +oil emulsion | Mice | [ |